Document is current
Any future updates will be listed below
-
Authors
Stolper, Rosa J. https://orcid.org/0000-0002-7890-7599
Tsang, Felice H.
Georgiades, Emily
Hanssen, Lars L. P. https://orcid.org/0000-0002-2551-2278
Tunnacliffe, Edward A. J. https://orcid.org/0000-0003-3939-744X
Downes, Damien J. https://orcid.org/0000-0002-5034-0869
Harrold, Caroline L. https://orcid.org/0000-0001-9140-0242
Hughes, Jim R. https://orcid.org/0000-0002-8955-7256
Beagrie, Robert A. https://orcid.org/0000-0003-1076-5595
Davies, Benjamin https://orcid.org/0000-0003-3623-600X
Kassouf, Mira T. https://orcid.org/0000-0002-9781-921X
Higgs, Douglas R. https://orcid.org/0000-0003-3579-8705
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/N00969X/1)
RCUK | Medical Research Council (MR/T014067/1)
Chinese Academy of Medical Sciences ((CIFMS) 2018-I2M-2-002)
RCUK | Biotechnology and Biological Sciences Research Council (BB/Y008898/1)
- License Information
-
More Information
Article History
Received: 15 March 2024
Accepted: 27 April 2026
First Online: 26 May 2026
Competing interests
: J.R.H. is a founder and shareholder of Nucleome Therapeutics; J.R.H. and D.J.D. are paid consultants for Nucleome Therapeutics. J.R.H. holds patents for Capture-C (nos. WO2017068379A1, EP3365464B1 and US10934578B2). These authors declare no other financial or non-financial interests. The remaining authors declare no competing interests.
